Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-20-000005

CEO bought 10,730 shares at $2.33 ($25,001)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-08-21 Purchase : show line 1 in the form +10,730 $2.33 $25,001 171,717 D
Open-market purchases · 10,730 sh · avg $2.33 · $25,001
Loading xslF345X03/primary_doc.xml…